about
Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosisATP-binding cassette transporters, atherosclerosis, and inflammationAdipose tissue macrophages promote myelopoiesis and monocytosis in obesityDisruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice.ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in miceActivation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1.Disordered haematopoiesis and athero-thrombosis.Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH childrenPegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cellsA Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease.HDL therapy: two kinds of right?Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis.Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles.Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis.Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.The modern interleukin-1 superfamily: Divergent roles in obesity.Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.RAGE Against the ABCs.Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.The iPSC Awakens ANGPTL3 in Tangier Disease.Proliferating macrophages populate established atherosclerotic lesions.Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile.Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.Impact of freezing on high-density lipoprotein functionality.Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.Deficiency of ATP-binding cassette transporter B6 in megakaryocyte progenitors accelerates atherosclerosis in mice.Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo.Sugar or Fat?-Metabolic Requirements for Immunity to Viral Infections.
P50
Q26861206-744F09FC-A322-4575-BD6E-3FAF71C98595Q27003068-488E143F-ABA3-4A0F-9062-6FBCE7CD582CQ33724394-D0F42692-0473-4A82-AAA2-12FFD6253AE8Q33757132-46B31648-4758-4A55-839F-25CD21F8AD03Q34144449-10E3613C-9C21-432F-AE00-09526902E756Q34324735-499EFFAB-AC8F-4C23-961A-3A78BC1316B2Q35370268-E15023F6-9A90-4FBF-8105-B8A6BE6266B3Q35858148-846DABDC-1607-40BD-A27C-D47FA78FC287Q35913725-7E3F4D28-795C-4F19-B686-99BCE0919C50Q35952700-49F1B4D6-3985-47D3-82ED-3D57CB8EC463Q36546975-F3B47A49-6E68-4E88-AACC-0608A53C4285Q36773876-5B9E994D-E0E9-40D8-8BA4-8C606654EC00Q36951483-E1D81DC5-AA7E-4F90-8088-901544C0031FQ37528535-9557D5C2-ABA1-4849-BE02-2C7DF86577ADQ37615062-A8483AE0-3E3D-4836-8357-8BE848F43120Q37739117-0346F37F-9A13-475F-9016-E8CAA2F82061Q37830075-8CB43D20-7258-4AD8-BC25-D04B1B17F86FQ38053137-CC7BF8C6-81E2-42B4-8581-D55DDB347838Q38259566-30F75ABF-8382-44A1-BA27-0108171F849AQ38616550-9078DEAD-A127-4EB8-A731-CD2227C04A68Q38635598-423A3955-E98F-4DCD-9367-0C568399AB8AQ38706492-92DA172D-6C0E-4CC5-A416-2B665527ED52Q38903993-DBAE3ABB-60DB-4A24-AE3F-83E0F1BCF01BQ38977852-86B81021-9FBA-4FFD-8605-293C078F472EQ40117639-BFBFE6A7-C495-446D-A88F-B8102AF77549Q41098823-2B3F0E2F-DE92-40CE-AFB0-850D6E95209FQ41299746-38E7F577-9F14-4CB5-8473-0028BA1C12C1Q41862465-273FD208-1955-4685-97ED-C4053E524BC2Q41983775-2F8630AF-266A-49A6-8C4E-8614FBABFE7EQ42004933-439D8BA2-C70B-46AD-A2D8-DD254B32F489Q42180113-94E91D73-6B09-4372-BC6B-C17AEBEBA2F9Q42186976-3EA8745C-68D9-49F2-9A75-4CA0B2FADF03Q45958086-B471D637-C76A-43C5-B703-11D68CD8067AQ46090651-7280AC53-4DE5-40AE-BE00-92F135CEDDDCQ46333846-2A97A5A0-B7DF-482F-B34C-E49DEF6B704EQ46575074-FFEFE47F-CF0D-41EC-96C9-FF80E62D302CQ46841200-334716B3-2C02-45AB-8487-C07C7FA27029Q46935048-FF0C132A-E578-400A-9831-A2192472A1A2Q47098423-564A273E-4D86-4ABE-B25D-7D16AA388E09Q47160410-70B0F8F7-2FEC-4183-A592-C8DACE0896A7
P50
description
researcher (ORCID 0000-0001-7039-7777)
@en
name
Andrew Murphy
@en
type
label
Andrew Murphy
@en
prefLabel
Andrew Murphy
@en
P31
P496
0000-0001-7039-7777